These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3778483)

  • 21. Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts.
    Rawlings CJ; Roberts JJ
    Mutat Res; 1986 Sep; 166(2):157-68. PubMed ID: 3762562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time scale of radiation damage by 2,4-dinitrophenyl-aziridine (CB 1954) in Chinese hamster cells: a rapid-mix study.
    Kandaiya S
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Sep; 48(3):441-6. PubMed ID: 3875583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
    Boland MP; Knox RJ; Roberts JJ
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):867-75. PubMed ID: 1901207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the protection by imidazoles against the cytotoxicity of the antitumour alkylating agents melphalan and CB 1954.
    Hickman JA; Melzack DH
    Biochem Pharmacol; 1976 Nov; 25(22):2489-91. PubMed ID: 985571
    [No Abstract]   [Full Text] [Related]  

  • 25. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemopotentiation by CB 1954: the importance of postincubations and the possible involvement of poly(ADP-ribosylation).
    Walling JM; Stratford IJ; Stephens MA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1661-4. PubMed ID: 6434498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds.
    Hickman JA; Melzack DH
    Biochem Pharmacol; 1975 Nov; 24(21):1947-52. PubMed ID: 1212244
    [No Abstract]   [Full Text] [Related]  

  • 28. Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.
    Maliepaard M; Wolfs A; Groot SE; de Mol NJ; Janssen LH
    Br J Cancer; 1995 Apr; 71(4):836-9. PubMed ID: 7536024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.
    Knox RJ; Friedlos F; Marchbank T; Roberts JJ
    Biochem Pharmacol; 1991 Oct; 42(9):1691-7. PubMed ID: 1930294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of phosphemide in combination with dexamethasone on DNA structure in sarcoma 45].
    Babaian IuS; Aslanian LL; Ananian GV; Garibian DV
    Biofizika; 1985; 30(3):414-7. PubMed ID: 4027269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and electron spin resonance study of spin-labelled compounds related to tumour-growth inhibitory nitroarylaziridines.
    Dodd NJ; Harcus RG; Preston PN
    Z Naturforsch C Biosci; 1976; 31(5-6):328-30. PubMed ID: 183409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
    Gibson NW; Zlotogorski C; Erickson LC
    Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
    Mandel HG; Connors TA; Melzack DH; Merai K
    Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemical mechanism of the radiation potentiating effects of 2,2-dimethylaziridine-type antitumor agents.
    Bardos TJ; Dunn JA; Perlman ME
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1653-6. PubMed ID: 536272
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of pretreatment of human tumour cells with MNNG on the DNA crosslinking and cytotoxicity of mitozolomide.
    Gibson NW; Erickson LC
    Br J Cancer; 1985 Aug; 52(2):251-8. PubMed ID: 4027167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity.
    Maliepaard M; Groot SE; de Mol NJ; Janssen LH; Freriks M; Verboom W; Reinhoudt DN; Stephens M; Stratford IJ
    Anticancer Drug Des; 1996 Jul; 11(5):403-13. PubMed ID: 8765532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.
    Bailey SM; Wyatt MD; Friedlos F; Hartley JA; Knox RJ; Lewis AD; Workman P
    Br J Cancer; 1997; 76(12):1596-603. PubMed ID: 9413948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
    Skladanowski A; Konopa J
    Br J Cancer; 2000 Apr; 82(7):1300-4. PubMed ID: 10755405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.